Novo Holdings and Healthcap launch new biotech firm

Novo Holdings is playing a crucial role in the establishment of the new biotech firm Tribune Therapeutics which will exploit a new pan-antifibrotic mechanism across a wide range of indications.
Photo: Novo Holdings / PR
Photo: Novo Holdings / PR
BY ANDREAS LØNSTRUP, TRANSLATED BY NIELSINE NIELSEN

Holdings company Novo Nordisk has established a new biotech firm, Tribune Therapeutics, according to a company press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading